Lian Liu

9PUBLICATIONS
5CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 26, 2026
First-Line Disitamab Vedotin, Tislelizumab, and S-1 in HER2-Overexpressing Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: A Single-Arm, Phase II Trial.

|May 23, 2026
Optimal First-line Immune-related Therapy Selection for Advanced Gastric Cancer: A Systematic Review and Network Meta-analysis.

|Mar 09, 2026
Patient-derived organoids predict chemotherapy response of locally advanced gastric cancer.

Miao Huang, Jiahui Chu, Wenbin Yu

|Sep 07, 2025
Development and validation of a machine learning model for predicting immune checkpoint inhibitor efficacy in advanced gastric cancer using dynamic changes in peripheral blood clinlabomics data: a retrospective multicenter cohort study.

Shulun Nie, Shuyi Song, Qian Xu

|Jul 01, 2025
Timing and clinical significance of chemotherapy in patients with resected gastric adenocarcinoma: a population-based cohort study.

Di Zhang, Qian Yang, Chunwang Ji

|May 15, 2025
N6-methyladenosine-regulated exosome biogenesis orchestrates an immunosuppressive pre-metastatic niche in gastric cancer peritoneal metastasis.

Song Li, Jianyuan Zhou, Shuang Wang

Pageof 2

Frequent Collaborators

2 joint publications

Song Li

1 joint publications

Dexin Yu

1 joint publications

Peng Gao

1 joint publications

Ping Wang